Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer

Recruiting N/A Interventional Study
Lung Cancer Driver Mutation
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Interventional
Purpose
Screening
Participants needed
1,753 (estimated)
Sponsor
University of California, Irvine · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This is a single-armed screening research study which screens immediate family member of lung cancer patients with a driver mutation to see if lung cancer can be inherited and whether researchers can find lung cancer early. Immediate family members of lung cancer patients will be 40-80 years old and screened using a low dose CT scan.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Cohort A: Inclusion Criteria: * Current diagnosis of lung cancer with a driver mutation. * Known driver mutation (e.g. via NGS, PCR, IHC, FISH, RT-PCR etc.) * Able and willing to give informed consent. * Able and willing to complete the screening questionnaire. Cohort A: Exclusion Criteria: * T…
Contacts

Chao Family Comprehensive Cancer Center University of California, Irvine

1-877-827-8839

ucstudy@uci.edu

CONTACT

University of California Irvine Medical

CONTACT